Initial sequencing analysis with Ion Torrent technology failed to detect the grossdeletion that covered complete exon 2 (c.-24-26_170 +5192del) of FBP1 gene and caused the delay in diagnosis.Deletion was then detected when sequencing was performed in an Illumina MiSeq platform.Conclusions: This case emphasizes the importance ofsequencing data analysis for precise diagnosis of rarediseases and therapy planning.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: Fructose-1,6-bisphosphatase deficiency (FBPasedeficiency, OMIM 229700) is an early-onset rare geneticdisorder caused by mutations in the FBP1 gene.Case presentation: Our patient was 17-years-old when shewas diagnosed with the disease.
📊
Key Findings & Data:Objectives: Fructose-1,6-bisphosphatase deficiency (FBPasedeficiency, OMIM 229700) is an early-onset rare geneticdisorder caused by mutations in the FBP1 gene.Case presentation: Our patient was 17-years-old when shewas diagnosed with the disease.
💡
Conclusion & Impact:Initial sequencing analysis with Ion Torrent technology failed to detect the grossdeletion that covered complete exon 2 (c.-24-26_170 +5192del) of FBP1 gene and caused the delay in diagnosis.Deletion was then detected when sequencing was performed in an Illumina MiSeq platform.Conclusions: This case emphasizes the importance ofsequencing data analysis for precise diagnosis of rarediseases and therapy planning.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objectives: Fructose-1,6-bisphosphatase deficiency (FBPasedeficiency, OMIM 229700) is an early-onset rare geneticdisorder caused by mutations in the FBP1 gene.Case presentation: Our patient was 17-years-old when shewas diagnosed with the disease. Initial sequencing analysis with Ion Torrent technology failed to detect the grossdeletion that covered complete exon 2 (c.-24-26_170 +5192del) of FBP1 gene and caused the delay in diagnosis.Deletion was then detected when sequencing was performed in an Illumina MiSeq platform.Conclusions: This case emphasizes the importance ofsequencing data analysis for precise diagnosis of rarediseases and therapy planning.
🔖
Cite This Article
ERGÖREN, M. Ç., TUNCEL, G., SAĞ, Ş. Ö., TEMEL, S. G. (2022). A rare case of fructose-1,6-bisphosphatase deficiency: a delayed diagnosis story. Türk Biyokimya Dergisi, Cilt: 45 - Sayı: 5, 613–616. https://ajindex.com/articles/620763
Li N, Chang G, Xu Y, Ding Y, Li G, Yu T, et al. Clinical and molecular characterization of patients with fructose 1,6-bisphosphatase deficiency (in eng). Int J Mol Sci 2017;18:857
Lebigot E, Brassier A, Zater M, Imanci D, Feillet F, Therond P, et al. ´ Fructose 1,6-bisphosphatase deficiency: clinical, biochemical and genetic features in French patients (in eng). J Inherit Metab Dis 2015;38:881–7. 3. el-Maghrabi MR, Lange AJ, Jiang W, Yamagata K, Stoffel M, Takeda J, et al. Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2–q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency (in eng). Genomics 1995; 27:520–5
Santer R, du Moulin M, Shahinyan T, Vater I, Maier E, Muntau AC, et al. A summary of molecular genetic findings in fructose1,6-bisphosphatase deficiency with a focus on a common longrange deletion and the role of MLPA analysis (in eng). Orphanet J Rare Dis, OriginalPaper 2016;11:1–7, 2016-04-21
Pinheiro FC, Sperb-Ludwig F, Ligabue-Braun R, Schüler-Faccini L, de Souza CF, Vairo F, et al. Genetic analysis of patients with fructose-1,6-bisphosphatase deficiency (in eng). Gene 2019;699: 102–9
Kikawa Y, Shin YS, Inuzuka M, Zammarchi E, Mayumi M. Diagnosis of fructose-1,6-bisphosphatase deficiency using cultured lymphocyte fraction: a secure and noninvasive alternative to liver biopsy (in eng). J Inherit Metab Dis 2002;25: 41–6
NCBI SG. Homo sapiens fructose-bisphosphatase 1 (FBP1), transcript variant 1, m – Nucleotide – NCBI. Available from: https://www.ncbi.nlm.nih.gov/pubmed/ [Accessed 2020]
Tran C. Inborn errors of fructose metabolism. What can we learn from them? (in eng). Nutrients 2017;9. https://doi.org/10.3390/ nu9040356
Pinto A, Alfadhel M, Akroyd R, Altınok YA, Bernabei SM, Bernstein L, et al. International practices in the dietary management of fructose 1-6 biphosphatase deficiency (in eng). Orphanet J Rare Dis 2018;13:21
Kilic M, Kasapkara CS, Yilmaz DY, Ozgul RK. Exon 2 deletion represents a common mutation in Turkish patients with fructose1,6-bisphosphatase deficiency (in eng). Metab Brain Dis 2019;34: 1487–91.